Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07264257 · ClinicalTrials.gov registry record · NA
Choline and Brain Functioning in Postmenopausal Women
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT07264257 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 38 participants.
The verdict
NCT07264257, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study will use a randomized placebo-controlled trial to examine a single oral dose of 1650 mg choline influences brain functioning as measured by fMRI.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Choline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2025-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07264257
The ClinicalTrials.gov registry entry for NCT07264257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07264257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07264257 about?
NCT07264257 is a clinical study titled "Choline and Brain Functioning in Postmenopausal Women". This study will use a randomized placebo-controlled trial to examine a single oral dose of 1650 mg choline influences brain functioning as measured by fMRI.
What is the current status of trial NCT07264257?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2022-06-15. Estimated completion is 2025-03-01.
What interventions are being tested in trial NCT07264257?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Choline (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07264257?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.